These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10424019)

  • 41. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
    Neutel JM; Smith DH; Reilly PA
    Int J Clin Pract; 1999; 53(3):175-8. PubMed ID: 10665127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hypertensive patients have to be doubly treated earlier. Which antihypertensive drug combination is appropriate to whom?].
    MMW Fortschr Med; 2003 May; 145(22):56. PubMed ID: 12866285
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Capillary blood cell velocity in finger nailfold: effect of enalapril and mibefradil in patients with mild to moderate hypertension.
    Martina B; Frach B; Surber C; Drewe J; Battegay E; Gasser P
    Microvasc Res; 1999 Mar; 57(2):94-9. PubMed ID: 10049657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [24-Hour arterial pressure profile in chronic obstructive lung diseases in combination with arterial hypertension treated with enalapril].
    Ol'binskaia LI; Belov AA
    Ter Arkh; 2002; 74(3):59-62. PubMed ID: 11980126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The efficiency of combinations of Enalapril and long-acting Nifedipin and Moxonidine in patients with arterial hypertension and a metabolic syndrome].
    Mananko EI; Vorob'eva EV; Kalashnikova TP; Bushkova EA; Krasnova NM; Idrisova EM; Vengerovskiĭ AI; Karpov RS; Gruzdeva OV; Kremenko SV
    Klin Med (Mosk); 2008; 86(7):56-61. PubMed ID: 18756750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Calcium antagonists vs ACE inhibitors in the treatment of essential arterial hypertension in the aged].
    Cellamare G; Poppa E; Sgobba G; Bianco G
    Minerva Cardioangiol; 1989 Mar; 37(3):111-8. PubMed ID: 2546102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of enalapril maleate on the lipid peroxidation processes and on the body's antioxidant system in patients with hypertension].
    Shapovalova SA
    Lik Sprava; 1999; (1):41-4. PubMed ID: 10423994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of enalapril maleate on vascular endothelial function and platelet-endothelial interactions in patients with essential hypertension].
    Iakovlev VM; Semenkin AA; Iudin SM; Nazarov AG; Kudriashov IL; Potapov VV; Korennova OIu; Il'iunykh LN
    Ter Arkh; 2000; 72(1):40-4. PubMed ID: 10687205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study on the effectiveness of enalapril as a monotherapy in mild to moderate hypertension.
    Poulose M; Jayadevan R; Peter JV; Cherian AM
    Indian J Med Sci; 1996 Jan; 50(1):1-3. PubMed ID: 8979626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
    Brunner HR; Bidiville J; Waeber G; Porchet M; Nussberger J; Waeber B
    Nephron; 1987; 47 Suppl 1():87-9. PubMed ID: 2827044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Bertram M
    Lancet; 2000 Dec; 356(9245):1926; author reply 1928-9. PubMed ID: 11130403
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of diltiazem on neurohumoral regulatory mechanisms in stenocardia patients].
    Kniaz'kova II; Belovol AN; Tsygankov AI
    Lik Sprava; 1998 Aug; (6):86-90. PubMed ID: 9844884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of amlodipine and enalapril alone and in combination on glomerular hemodynamics in a hypertensive patient with unilaterally contracted kidney.
    Passavanti G; Vernaglione L; Mancini A
    Nephron; 1998; 78(3):350-1. PubMed ID: 9546705
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-II hypertension].
    Vladkovs'kyĭ IK; Plesh IA; Haĭdukov VA; Loboda MI
    Lik Sprava; 1996; (3-4):113-7. PubMed ID: 9035842
    [No Abstract]   [Full Text] [Related]  

  • 60. Diltiazem: ten years of clinical experience in the treatment of hypertension.
    Weir MR
    J Clin Pharmacol; 1995 Mar; 35(3):220-32. PubMed ID: 7608309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.